AVEO Oncology completes first interim analysis in global Phase 3 FIERCE-HN study

Cedar Health Research opens new embedded research site within Texas Native Health

Hansa's imlifidase Biologics License Application accepted by FDA

Novartis reports positive Phase III results for remibrutinib in chronic inducible urticaria

Merck and Mayo Clinic launch AI-driven drug discovery collaboration

Palisade Bio makes Clinical Advisory Board appointment

Curasight announces presentation at TD Cowen's 46th Annual Health Care Conference in Boston

Compass Pathways reports second positive phase 3 result for COMP360 in treatment-resistant depression

Sanofi and Teva report durable phase 2b maintenance efficacy for duvakitug in ulcerative colitis and Crohn's disease

Nucleome Therapeutics names new chief scientific officer

Eli Lilly and Company reports positive Phase 3 LIBRETTO-432 results for Retevmo in early-stage RET fusion-positive NSCLC

Celltrion data show subcutaneous infliximab restores disease control after treatment interruption

Cambridge Cognition expands into India through Ivory commercialisation agreement

Genentech reports positive Phase III MAJESTYdata for Gazyva in primary membranous nephropathy

Ella immunoassay platform gains CE‑IVD approval in the EU